Bernd Eisele
Chief Executive Officer at Vakzine Projekt Management GmbH
Bernd Eisele active positions
| Companies | Position | Start | End |
|---|---|---|---|
Vakzine Projekt Management GmbH
 Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany. | Chief Executive Officer | 2009-11-15 | - |
| Chief Tech/Sci/R&D Officer | 2009-11-15 | - |
Career history of Bernd Eisele
Former positions of Bernd Eisele
| Companies | Position | Start | End |
|---|---|---|---|
Behringwerke AG
 Behringwerke AG Pharmaceuticals: OtherHealth Technology Part of Sanofi, Behringwerke AG is a German company that produces specialty chemicals and pharmaceutical products. The company is based in Marburg, Germany. | Corporate Officer/Principal | 1995-12-31 | 1995-12-31 |
| Abbott Products GmbH | Corporate Officer/Principal | 1995-12-31 | - |
Training of Bernd Eisele
| Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Statistics
International
| Germany | 5 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Behringwerke AG
Behringwerke AG Pharmaceuticals: OtherHealth Technology Part of Sanofi, Behringwerke AG is a German company that produces specialty chemicals and pharmaceutical products. The company is based in Marburg, Germany. | Health Technology |
Vakzine Projekt Management GmbH
Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany. | Health Technology |
| Abbott Products GmbH |
- Stock Market
- Insiders
- Bernd Eisele
- Experience
